Skip to content
Stop using now Drug recall · FDA · Published December 28, 2023

Fresenius Recalls DELFLEX Dialysis Solution Due to Sterility Risk

Fresenius Medical Care recalls specific lots of DELFLEX Peritoneal Dialysis Solution due to a lack of sterility assurance. Check your lot number immediately.

🇺🇸 FDA recall #D-0218-2024DrugFresenius Medical Care ›
Take action

Contact the company

Recalling firmFresenius Medical Care Holdings, Inc.920 Winter St Bld 920 · Waltham, MA 02451-1521
✎ GovInfoNow plain-language explainer

Fresenius Medical Care Holdings, Inc. is recalling DELFLEX Peritoneal Dialysis Solution in Biofine containers containing 1.5% Dextrose. The recall affects 6000mL bags distributed nationwide due to a lack of sterility assurance. This means the product may not be free from harmful microorganisms. Read more at govinfonow.com/recall/32908-fresenius-recalls-delflex-dialysis-solution-due-to-sterility-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32908-fresenius-recalls-delflex-dialysis-solution-due-to-sterility-risk · Updated October 9, 2026 · FDA enforcement record: FDA #D-0218-2024

Cite this page

“Fresenius Recalls DELFLEX Dialysis Solution Due to Sterility Risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32908-fresenius-recalls-delflex-dialysis-solution-due-to-sterility-risk. Based on FDA recall #D-0218-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0218-2024%22&limit=1).

Fresenius Medical Care Holdings, Inc. voluntarily recalled DELFLEX Peritoneal Dialysis Solution due to a lack of sterility assurance, according to the FDA on Dec. 28, 2023.

How to tell if you have it

  • Brand: Fresenius Medical Care
  • Product: DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose
  • Packaging: 6000mL bags
  • NDC: 49230-206-62
  • Part Number: 077-60621
  • Lot #: 23JK02010
  • Exp. Date: 1/31/2025

The hazard

The product poses a lack of sterility assurance hazard, according to the FDA.

Context

GovInfoNow's records show Fresenius Medical Care Holdings, Inc. has 44 other recalls on record since April 14, 2014. Other recent recalls include Fresenius Bicarby Dialysate leaks (May 12, 2026), Fresenius 5008X Blood Tubing Set errors (May 11, 2026), and Fresenius Medical Care Bicarby Dialysate labeling issues (May 7, 2026). Similar product recalls include Fresenius Kabi 5% Dextrose Injection, 0.9% Sodium Chloride Injection, and 1000mL Sodium Chloride Injection, all citing lack of sterility assurance on March 11, 2026.

How to tell if you have this one

Look for DELFLEX Peritoneal Dialysis Solution in Biofine containers with 1.5% Dextrose in 6000mL bags. Check for NDC 49230-206-62, Part Number 077-60621, and Lot # 23JK02010 with an expiration date of 1/31/2025.

  • Brand
    Fresenius Medical Care
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Product Details

    Verify if your bag matches NDC 49230-206-62, Part Number 077-60621, and Lot # 23JK02010.

  2. Stop Using the Product

    Do not use the solution if it matches the recalled lot numbers due to sterility risks.

  3. Contact Your Healthcare Provider

    Reach out to your doctor or dialysis center immediately for guidance on alternative treatment options.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 13 days after the firm started it.

1. Firm started the recall: Dec 28, 202312. FDA classified it Class II: Jan 4, 202423. Published in FDA’s Enforcement Report: Jan 10, 2024320232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was this product sold?

The product was distributed nationwide within the United States.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0218-2024 (December 28, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0218-2024 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA